Barclays upgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Free Report) to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports.
MURGY has been the subject of a number of other research reports. Jefferies Financial Group lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "buy" rating to a "hold" rating in a research report on Monday, October 21st. UBS Group lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research report on Thursday, December 19th. Finally, Berenberg Bank lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research report on Friday, October 25th.
Check Out Our Latest Report on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance
Shares of OTCMKTS MURGY traded down $0.08 on Tuesday, hitting $11.01. The company's stock had a trading volume of 273,856 shares, compared to its average volume of 446,015. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 12-month low of $8.40 and a 12-month high of $11.20. The company has a market capitalization of $73.63 billion, a price-to-earnings ratio of 7.16, a price-to-earnings-growth ratio of 1.73 and a beta of 1.02. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.12 and a quick ratio of 1.12. The stock has a 50 day moving average of $10.43 and a 200-day moving average of $10.37.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile
(
Get Free Report)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
See Also
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
